Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows results have been posted and the design uses parallel assignment (replacing the prior single-group setup), along with updated results dates and related documents (Informed Consent Form and Study Protocol/SAP).
    Difference
    2%
    Check dated 2026-05-14T22:55:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision was updated to v3.5.3, replacing the previous v3.5.2. This reflects a metadata/version update rather than changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T15:42:26.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T09:28:08.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays 'Results Submitted' to indicate that trial results have been posted, replacing the previous 'No Results Posted' notification. The change clarifies the availability of outcomes for users reviewing the trial.
    Difference
    0.1%
    Check dated 2026-03-25T21:00:38.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:05.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:24:34.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.